# Egis Pharmaceuticals

News31.08.2017.

JGL achieves positive business results with a profit of HRK 44.41 million

In the first half of the year, JGL achieved total revenue and sales revenue growth at the level of the joint-stock company (d.d.) and at the Group level.

News08.02.2017.

JGL capitalizes on the leading market position of its brands in Russia

The pharmaceutical company JGL d.d. sold its Russian product portfolio of the brand D-Panthenol and women's health products to the Egis Pharmaceuticals company in Hungary. In addit...